Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,425,515 papers from all fields of science
Search
Sign In
Create Free Account
pasireotide
Known as:
Pasireotida
, Cyclo((4R)-4-(2-aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L-phenylalanyl-)
, cyclo((4R)-4-(2-Aminoethylcarbamoyloxy)-L-prolyl-L-phenylglycyl-D-tryptophyl-L-lysyl-4-O-benzyl-L-tyrosyl-L- phenylalanyl-)
Expand
A synthetic long-acting cyclic peptide with somatostatin-like activity. Pasireotide activates a broad spectrum of somatostatin receptors, exhibiting…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
1 ML pasireotide 0.3 MG/ML Injection
1 ML pasireotide 0.6 MG/ML Injection
analogs & derivatives
pasireotide 40 MG Injection
Expand
Broader (2)
Hormones
Somatostatin
Narrower (2)
SOM-230
pasireotide diaspartate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Pasireotide for the treatment of refractory hypoglycaemia from malignant insulinoma
Nicholas S. Hendren
,
Kamaldeep Panach
,
+4 authors
S. Mirfakhraee
Clinical Endocrinology
2018
Corpus ID: 30703738
Dear Editor, Insulinomas are rare, usually solitary benign tumours. The presence of metastases defines malignant insulinomas.1…
Expand
Review
2016
Review
2016
Neuroendocrine tumours - Medical therapy: Biological.
A. Rinke
,
S. Krug
Best practice & research. Clinical endocrinology…
2016
Corpus ID: 19292077
Review
2014
Review
2014
Molecular basis of pharmacological therapy in Cushing’s disease
D. Ferone
,
C. Pivonello
,
G. Vitale
,
M. Zatelli
,
A. Colao
,
R. Pivonello
Endocrine
2014
Corpus ID: 31354257
Abstract Cushing’s disease (CD) is a severe endocrine condition caused by an adrenocorticotropin (ACTH)-producing pituitary…
Expand
Review
2013
Review
2013
Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors.
R. Feelders
,
W. D. de Herder
,
S. Neggers
,
A. J. van der Lely
,
L. Hofland
Drugs of Today
2013
Corpus ID: 32792383
Somatostatin receptors are an important target for medical treatment of pituitary and neuroendocrine tumors. To date, five…
Expand
Review
2011
Review
2011
Somatostatin analogs for the treatment of neuroendocrine tumors
M. Culler
,
K. Öberg
,
R. Arnold
,
E. Krenning
,
I. Sevilla
,
J. Díaz
Cancer Metastasis Review
2011
Corpus ID: 33959072
Somatostatin is an important regulator of endocrine and exocrine secretion, affecting the release of many hormones. The effects…
Expand
Review
2008
Review
2008
Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
H. Tomoda
,
T. Doi
Accounts of Chemical Research
2008
Corpus ID: 6534615
For discovery of a new type of antiatherosclerotic agents, a cell-based assay of lipid droplet accumulation using primary mouse…
Expand
1989
1989
C(3)-cyclopropyl cephems and carbacephems.
D. Spry
,
N. Snyder
,
J. S. Kasher
Journal of antibiotics (Tokyo. )
1989
Corpus ID: 26134417
A series of C(3)-cyclopropyl cephems and carbacephems has been prepared by palladium catalyzed addition of diazomethane to the…
Expand
1978
1978
Mitochondrial transfer RNAs in yeast: identification of isoaccepting transfer RNAs.
N. Martin
,
M. Rabinowitz
Biochemistry
1978
Corpus ID: 27990971
To delineate the total number of tRNAs encoded by yeast mitochondrial DNA (mtDNA), we have examined mitochondrial tRNA…
Expand
1973
1973
Some physical and biological properties of 4-thiouridine- and dihydrouridine-deficient tRNA from chloramphenicol-treated Escherichia coli.
L. C. Waters
,
L. Shugart
,
W. Yang
,
A. Best
Archives of Biochemistry and Biophysics
1973
Corpus ID: 10145715
Highly Cited
1962
Highly Cited
1962
A highly potent analogue of oxytocin, desamino-oxytocin.
D. Hope
,
V. V.
,
S. Murti
Journal of Biological Chemistry
1962
Corpus ID: 27820880
The functional groups in the oxytocin molecule consist, from a chemical standpoint, of a primary amino, a phenolic hydroxyl…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required